MYC and neoplasm: Silencing of MYC in multiple tumor models by using small interfering (si)RNAs leads to tumor regression (Han et al., 2019; Jain et al., 2002; Shachaf and Felsher, 2005), suggesting that MYC may be exploited for therapy.